Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Debt Ratio (2016 - 2025)

Cytosorbents (CTSO) has disclosed Debt Ratio for 9 consecutive years, with 0.32 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt Ratio rose 10.25% year-over-year to 0.32, compared with a TTM value of 0.32 through Sep 2025, up 10.25%, and an annual FY2024 reading of 0.3, up 212.04% over the prior year.
  • Debt Ratio was 0.32 for Q3 2025 at Cytosorbents, up from 0.3 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.32 in Q3 2025 and bottomed at 0.08 in Q4 2022.
  • Average Debt Ratio over 4 years is 0.19, with a median of 0.18 recorded in 2023.
  • The sharpest move saw Debt Ratio soared 212.04% in 2024, then rose 10.25% in 2025.
  • Year by year, Debt Ratio stood at 0.08 in 2022, then rose by 19.74% to 0.09 in 2023, then skyrocketed by 212.04% to 0.3 in 2024, then rose by 7.77% to 0.32 in 2025.
  • Business Quant data shows Debt Ratio for CTSO at 0.32 in Q3 2025, 0.3 in Q2 2025, and 0.3 in Q4 2024.